GLIMIP MF 2 850SR (Glimepiride (2mg) + Metformin (850mg))

GLIMIP MF 2mg/850mg Tablet SR is classified within the anti-diabetic medication category and is specifically formulated for the management of type 2 diabetes mellitus in adult patients. This pharmaceutical formulation combines two active components to assist in regulating glucose levels in individuals diagnosed with diabetes. For optimal effectiveness, it is advised to administer the tablet alongside a meal and adhere to a consistent schedule for ingestion on a daily basis. The prescribing physician will determine the appropriate dosage, which may undergo adjustments based on the patient’s blood sugar monitoring results over time. It is essential for patients to continue this medication consistently, even if they are feeling well or their glucose levels appear stable. Discontinuation without medical consultation poses significant risks, including elevated blood glucose levels that could potentially lead to serious complications such as renal impairment, vision loss, neuropathy, and amputations. A comprehensive treatment plan for diabetes should also incorporate a balanced diet, routine physical activity, and weight management as directed by healthcare professionals, as these factors significantly contribute to effective diabetes control. Patients should be vigilant for signs of hypoglycemia, including sweating, dizziness, headaches, and tremors, and maintain regular meal intake while carrying a quick source of glucose, such as candy or fruit juice, at all times. The consumption of alcohol should be avoided, as it may heighten the risk of hypoglycemia. Additional adverse effects may include altered taste sensations, nausea, gastrointestinal disturbances, headaches, and respiratory infections. Weight gain has also been reported by some individuals using this medication. Individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic conditions should refrain from using this medication. Prior to commencement, it is critical to disclose any history of cardiovascular issues to your healthcare provider. Regular monitoring of blood glucose levels and potential liver function tests is advisable throughout the course of treatment.